Intra-Cellular Therapies Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
68.69
|
|
Average Rating
|
4.46
|
|
# Strong Buys
|
8
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.81
|
-0.57
|
0.24
|
29.63%
|
|
2022-06-30
|
-0.76
|
-0.92
|
-0.16
|
-21.05%
|
|
2022-03-31
|
-0.92
|
-0.78
|
0.14
|
15.22%
|
|
2021-12-31
|
-0.99
|
-1.05
|
-0.06
|
-6.06%
|
|
2021-09-30
|
-0.92
|
-0.95
|
-0.03
|
-3.26%
|
|
2021-06-30
|
-0.79
|
-0.85
|
-0.06
|
-7.59%
|
|
2021-03-31
|
-0.80
|
-0.65
|
0.15
|
18.75%
|
|
2020-12-31
|
-0.85
|
-0.76
|
0.09
|
10.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.27
|
|
2021-12-31
|
-3.50
|
|
2020-12-31
|
-3.24
|
|
2019-12-31
|
-2.68
|
|
2018-12-31
|
-2.84
|
|
2017-12-31
|
-2.12
|
|
2016-12-31
|
-2.69
|
|
2015-12-31
|
-2.91
|
|
2014-12-31
|
-1.06
|
|
2013-12-31
|
-0.30
|